Novocure Ltd
NASDAQ:NVCR

Watchlist Manager
Novocure Ltd Logo
Novocure Ltd
NASDAQ:NVCR
Watchlist
Price: 17.73 USD 3.74% Market Closed
Market Cap: 1.9B USD
Have any thoughts about
Novocure Ltd?
Write Note

Wall Street
Price Targets

NVCR Price Targets Summary
Novocure Ltd

Wall Street analysts forecast NVCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NVCR is 27.25 USD with a low forecast of 18.18 USD and a high forecast of 42 USD.

Lowest
Price Target
18.18 USD
3% Upside
Average
Price Target
27.25 USD
54% Upside
Highest
Price Target
42 USD
137% Upside

NVCR Last Price Targets
Novocure Ltd

The latest public price target was made on Oct 16, 2024 by Emily Bodnar from H.C. Wainwright , who expects NVCR stock to rise by 69% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Emily Bodnar
H.C. Wainwright
30 USD
Upside 69%
1 month ago
Oct 16, 2024
H.C. Wainwright Upgrades NovoCure Ltd. (NVCR) to Buy
StreetInsider
Emily Bodnar
H.C. Wainwright
24 USD
Upside 35%
3 months ago
Jul 26, 2024
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright
StreetInsider
Emily Bodnar
H.C. Wainwright
22 USD
Upside 24%
6 months ago
May 3, 2024
NovoCure Ltd. (NVCR) PT Lowered to $22 at H.C. Wainwright
StreetInsider
Vijay Kumar
Evercore ISI
14.5 USD
Downside 18%
6 months ago
May 2, 2024
NovoCure Ltd. (NVCR) PT Lowered to $14.50 at Evercore ISI
StreetInsider
Jason Bednar
Piper Sandler
28 USD
Upside 58%
7 months ago
Apr 10, 2024
NovoCure Ltd. (NVCR) PT Raised to $28 at Piper Sandler
StreetInsider
Larry Biegelsen
Wells Fargo
42 USD
Upside 137%
7 months ago
Apr 3, 2024
NovoCure Ltd. (NVCR) PT Lowered to $42 at Wells Fargo
StreetInsider
Unknown Analyst
H.C. Wainwright
24 USD
Upside 35%
7 months ago
Mar 27, 2024
NovoCure Ltd. (NVCR) PT Raised to $24 at H.C. Wainwright following positive METIS data
StreetInsider
Show More Price Targets
Show Less Price Targets
Emily Bodnar
H.C. Wainwright
Price Target 30 USD
Upside/Downside 69%
View Source
Emily Bodnar
H.C. Wainwright
Price Target 24 USD
Upside/Downside 35%
View Source
Emily Bodnar
H.C. Wainwright
Price Target 22 USD
Upside/Downside 24%
View Source
Vijay Kumar
Evercore ISI
Price Target 14.5 USD
Upside/Downside 18%
View Source
Jason Bednar
Piper Sandler
Price Target 28 USD
Upside/Downside 58%
View Source
Larry Biegelsen
Wells Fargo
Price Target 42 USD
Upside/Downside 137%
View Source
Unknown Analyst
H.C. Wainwright
Price Target 24 USD
Upside/Downside 35%
View Source
Show More Price Targets
Show Less Price Targets
Novocure Ltd Competitors:
Price Targets
DXCM
Dexcom Inc
34% Upside
9996
Peijia Medical Ltd
29% Upside
MOVE
Medacta Group SA
30% Upside
ELMD
Electromed Inc
13% Upside
MEDI
Medistim ASA
19% Upside
4595
Mizuho Medy Co Ltd
22% Downside
PEN
Penumbra Inc
2% Downside
002901
Double Medical Technology Inc
53% Upside

Revenue
Forecast

Revenue Estimate
Novocure Ltd

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 41%. The projected CAGR for the next 3 years is 11%.

41%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

Net Income Estimate
Novocure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-18%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NVCR's stock price target?
Price Target
27.25 USD

According to Wall Street analysts, the average 1-year price target for NVCR is 27.25 USD with a low forecast of 18.18 USD and a high forecast of 42 USD.

What is Novocure Ltd's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for Novocure Ltd's revenue is 41%. The projected CAGR for the next 3 years is 11%.

Back to Top